Restore Prescription Drugs Discount Act
Sponsored By: Senator Paul, Rand [R-KY]
Introduced
Summary
This bill would repeal the Robinson-Patman Act and remove federal limits on price discrimination and related antidiscrimination rules. The bill uses the short title Restore Prescription Drugs Discount Act to frame that change.
Show full summary
- Drug manufacturers and suppliers in the prescription drug market would no longer be bound by the Robinson-Patman Act's prohibitions on offering different prices or discounts.
- Pharmacies, hospitals, and other drug purchasers would lose the specific statutory protections against discriminatory pricing that the Act provided.
- The repeal removes the Robinson-Patman provisions from the U.S. Code and does not add funding, new programs, or transition rules in the bill text.
Personalized for You
How does this bill affect your finances?
Personalize government policy and PRIA will tell you what this bill means for your household, plus every other piece of legislation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Bill Overview
Analyzed Economic Effects
1 provisions identified: 0 benefits, 0 costs, 1 mixed.
Repeal of Robinson-Patman price law
This bill would repeal the Act of June 19, 1936, known as the Robinson-Patman Act. If enacted, it would remove federal limits on certain price differences and discount terms. Manufacturers, wholesalers, distributors, and retailers would face different legal rules for pricing and discounts. Consumers and small businesses could see prices change, but the direction and size of changes would vary by market.
Sponsors & CoSponsors
Sponsor
Paul, Rand [R-KY]
KY • R
Cosponsors
There are no cosponsors for this bill.
Roll Call Votes
No roll call votes available for this bill.
View on Congress.gov